AbbVie buys neuroscience drug developer Cerevel Therapeutics for $8.7 billion
American pharmaceutical company AbbVie announced on the purchase of neurological drug developer Cerevel Therapeutics. AbbVie will pay $45 for each...
American pharmaceutical company AbbVie announced on the purchase of neurological drug developer Cerevel Therapeutics. AbbVie will pay $45 for each...
American biopharmaceutical company AbbVie will buy neurological drug developer Cerevel Therapeutics for $8.7 billion at $45 per share. The transaction...
American pharmaceutical company Bristol Myers Squibb buys cancer drug developer Mirati Therapeutics. The corresponding agreement was signed by the companies...
The American pharmaceutical company Bristol Myers Squibb (BMS) has entered into an agreement to purchase Mirati Therapeutics, which is developing...
Today, December 12, American biotechnology company Amgen announced on the purchase of the Irish pharmaceutical company Horizon Therapeutics. The deal...
The American pharmaceutical company Pfizer buys drug developer Global Blood Therapeutics (GBT), informs Pfizer press office. The transaction amount will...
Pharmaceutical company Pfizer has entered into talks to buy drug maker Global Blood Therapeutics (GBT) for $5 billion. informed The...